{"id":14504,"date":"2013-11-06T11:32:30","date_gmt":"2013-11-06T10:32:30","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=14504"},"modified":"2021-09-28T11:35:25","modified_gmt":"2021-09-28T09:35:25","slug":"ariza-ariza-r-van-walsem-a-canal-c-roldan-c-betegon-l-oyaguez-i-janssen-k","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/ariza-ariza-r-van-walsem-a-canal-c-roldan-c-betegon-l-oyaguez-i-janssen-k\/","title":{"rendered":"Ariza-Ariza R, Van Walsem A, Canal C, Rold\u00e1n C, Beteg\u00f3n L, Oyag\u00fcez I, Janssen K"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/>Ariza-Ariza R, Van Walsem A, Canal C, Rold\u00e1n C, Beteg\u00f3n L, Oyag\u00fcez I, Janssen K<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6 style=\"text-align: justify;\">Cost-minimization analysis of subctuaneous abatacept in the treatment of rheumatoid arthritis in Spain<\/h6>\n<h6 style=\"text-align: justify;\"><strong>16th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/125.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ariza-Ariza R, Van Walsem A, Canal C, Rold\u00e1n C, Beteg\u00f3n L, Oyag\u00fcez I, Janssen K &nbsp; &nbsp; Cost-minimization analysis of subctuaneous abatacept in the treatment of rheumatoid arthritis in Spain 16th Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[937,919,246],"tags":[],"class_list":["post-14504","post","type-post","status-publish","format-quote","hentry","category-amc-ac-tipo-de-proyecto","category-enfermedades-autoinmunes","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14504"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=14504"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14504\/revisions"}],"predecessor-version":[{"id":14506,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/14504\/revisions\/14506"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=14504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=14504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=14504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}